Skip to content
DefDex

Federal award

FLOW PHARMA, INC.

W911QY18P0298

ContractSBIR/STTR ST1

Obligated and Ceiling

Obligated (net)
$136,773.00
Ceiling (potential value, not spending)
$136,773.00
Current value
$136,773.00
Gross positive obligations
$136,773.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
FLOW PHARMA, INC. · JPU1CSU7D998
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
FLOW PHARMA, INC. · J3DJA4HJPQF1
Awarding agency
Department of War · sub-agency 2100 · office W911QY
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Industry (NAICS)
541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PIID
W911QY18P0298
Award type code
B
Actions
1 · Sep 20, 2018 to Sep 20, 2018
Why it is listed
gross positive obligations of $100k or more (contracts); SBIR/STTR award

Open this award on USAspending →

Action History1

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 20, 2018FY20180—$136,773.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.